journal article·2019-10-25Open access

Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells

Francesca Biscaglia, Giorgio Ripani, Senthilkumar Rajendran, Clara Benna, Simone Mocellin, Gianfranco Bocchinfuso, Moreno Meneghetti, Antonio Palleschi, Marina Gobbo

ACS Applied Nano Materials· Volume 2· Issue 10

Abstract

The active targeting strategy has emerged as a promising approach to achieve selectivity in nanobiotechnology applications. Peptides are particularly suited as targeting moieties because the multivalent presentation of these small molecules on a nanoparticle provides high avidity for the target. However, to achieve an efficient targeting activity, the presentation of the peptide on the nanostructure has to be supported by an appropriate design. To optimize the targeting to colorectal cancer cells, we have performed a ligand design study of plasmonic nanostructures covered with a cyclic RGD peptide, a known targeting moiety for the αvβ3 integrin. We find that to achieve a good targeting activity, the RGD peptide has to be linked to plasmonic nanostructures through a long PEG chain and a short oligolysine spacer. When the cyclic RGD peptide is directly linked to the PEG chains of the nanostructures, their targeting ability is lost. Molecular dynamics calculations make possible to understand the difference of the peptide organization in two targeted nanosystems, unveiling an effect of the spacer on the orientation of the active component, which very likely positively affects the targeting properties of the investigated plasmonic nanostructures.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cell Adhesion Molecules Research · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padova, Italy

Department of Chemical Science and Technologies, University of Rome “Tor Vergata” and CSGI unit of Rome, Via della Ricerca Scientifica, 00133 Rome, Italy

Department of Surgery Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, 35124 Padova, Italy

First Surgical Clinic, Azienda Ospedaliera Padova, Via Giustiniani 2, 35124 Padova, Italy

Surgical Oncology Unit, Istituto Oncologico Veneto (IOV-IRCCS),Via Gattamelata, 64, 35128 Padova, Italy

Funding

Partnership for Advanced Computing in Europe AISBL · Associazione Italiana per la Ricerca sul Cancro · Ministero della Salute · Universit?? degli Studi di Padova

References (71)

Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1002/wnan.6610.1002/wnan.66 ↗
4. 10.2217/nnm.10.2310.2217/nnm.10.23 ↗
5. 10.1021/acsnano.5b0132010.1021/acsnano.5b01320 ↗
6. 10.1021/ja208433810.1021/ja2084338 ↗
7. 10.1016/0021-9797(91)90043-810.1016/0021-9797(91)90043-8 ↗
8. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
9. 10.2217/nnm.11.1910.2217/nnm.11.19 ↗
10. 10.1016/j.jconrel.2016.11.01510.1016/j.jconrel.2016.11.015 ↗
11. 10.1038/nrc90310.1038/nrc903 ↗
12. 10.2217/nnm.10.11310.2217/nnm.10.113 ↗
13. 10.1038/sj.bjc.660157610.1038/sj.bjc.6601576 ↗
14. 10.1016/j.hoc.2004.09.01010.1016/j.hoc.2004.09.010 ↗
15. 10.1172/JCI11581110.1172/JCI115811 ↗
16. 10.1126/science.751275110.1126/science.7512751 ↗
17. 10.1074/jbc.M20163020010.1074/jbc.M201630200 ↗
18. 10.1038/modpathol.388044710.1038/modpathol.3880447 ↗
19. 10.1097/00006676-200308000-0001310.1097/00006676-200308000-00013 ↗
20. 10.1038/nm0902-91810.1038/nm0902-918 ↗
21. 10.1002/anie.19971374110.1002/anie.199713741 ↗
22. 10.1021/acsami.8b1045210.1021/acsami.8b10452 ↗
23. 10.1016/j.jconrel.2017.11.03310.1016/j.jconrel.2017.11.033 ↗
24. 10.1039/C8RA02125B10.1039/C8RA02125B ↗
25. 10.1021/bc100448r10.1021/bc100448r ↗
26. 10.1039/C6RA21568H10.1039/C6RA21568H ↗
27. 10.1021/acsami.5b1173010.1021/acsami.5b11730 ↗
28. 10.1038/srep3405310.1038/srep34053 ↗
29. 10.1016/j.ijpharm.2017.05.06810.1016/j.ijpharm.2017.05.068 ↗
30. 10.1021/acsami.8b0826910.1021/acsami.8b08269 ↗
31. 10.1016/j.jconrel.2011.08.00310.1016/j.jconrel.2011.08.003 ↗
32. 10.1016/j.ijpharm.2017.11.01010.1016/j.ijpharm.2017.11.010 ↗
33. 10.1002/adhm.20120000610.1002/adhm.201200006 ↗
34. 10.1166/jbn.2015.208710.1166/jbn.2015.2087 ↗
35. 10.1021/nn305663e10.1021/nn305663e ↗
36. 10.1021/acs.molpharmaceut.8b0061210.1021/acs.molpharmaceut.8b00612 ↗
37. 10.1039/C3TB21422B10.1039/C3TB21422B ↗
38. 10.1016/j.phrs.2010.03.00510.1016/j.phrs.2010.03.005 ↗
39. 10.1021/nn403395410.1021/nn4033954 ↗
40. 10.1039/C5CC06661A10.1039/C5CC06661A ↗
41. 10.1016/S0142-9612(00)00193-910.1016/S0142-9612(00)00193-9 ↗
42. 10.1002/jps.2009810.1002/jps.20098 ↗
43. 10.1016/j.jconrel.2018.03.00210.1016/j.jconrel.2018.03.002 ↗
44. 10.1002/adfm.20140309510.1002/adfm.201403095 ↗
45. 10.1002/adhm.20170059610.1002/adhm.201700596 ↗
46. 10.1002/adfm.20110153910.1002/adfm.201101539 ↗
47. 10.1021/acs.chemrev.5b0026510.1021/acs.chemrev.5b00265 ↗
48. 10.1039/C7CS00172J10.1039/C7CS00172J ↗
49. 10.1021/ar800243b10.1021/ar800243b ↗
50. 10.1002/smll.20120119610.1002/smll.201201196 ↗
51. 10.1002/psc.51210.1002/psc.512 ↗
52. 10.1016/j.msec.2019.10976210.1016/j.msec.2019.109762 ↗
53. 10.1016/j.softx.2015.06.00110.1016/j.softx.2015.06.001 ↗
54. 10.1002/jcc.2009010.1002/jcc.20090 ↗
55. 10.1021/ct300245h10.1021/ct300245h ↗
56. 10.1088/0957-4484/18/42/42400710.1088/0957-4484/18/42/424007 ↗
57. 10.1126/science.106904010.1126/science.1069040 ↗
58. 10.1002/jcc.2008410.1002/jcc.20084 ↗
59. Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; Hermans, J. In Intermolecular Forces; Pullman, B., Ed. Reidel: Dordrecht, 1981; pp 331–342.10.1007/978-94-015-7658-1_21 ↗
60. 10.1007/s00018-011-0719-110.1007/s00018-011-0719-1 ↗
61. 10.1016/j.bbamem.2012.11.03310.1016/j.bbamem.2012.11.033 ↗
62. 10.1016/j.bbamem.2014.11.00210.1016/j.bbamem.2014.11.002 ↗
63. 10.1063/1.47011710.1063/1.470117 ↗
64. 10.1063/1.240842010.1063/1.2408420 ↗
65. 10.1063/1.44811810.1063/1.448118 ↗
66. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗
67. 10.1021/jp060509210.1021/jp0605092 ↗
68. 10.1016/j.jcis.2018.08.10710.1016/j.jcis.2018.08.107 ↗
69. 10.1038/8668410.1038/86684 ↗
70. 10.1039/C9CP02015B10.1039/C9CP02015B ↗
71. 10.1021/ja960372110.1021/ja9603721 ↗